行情

BPMX

BPMX

BIOPHARMX
AMEX

实时行情|Nasdaq Last Sale

0.2711
-0.0049
-1.78%
交易中 12:29 04/02 EDT
开盘
0.2830
昨收
0.2760
最高
0.2899
最低
0.2700
成交量
23.90万
成交额
--
52周最高
2.700
52周最低
0.2500
市值
495.52万
市盈率(TTM)
-0.3267
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测BPMX价格均价为2.250,最高价位2.250,最低价为2.250。

EPS

BPMX 新闻

更多
  • 英国央行新量化宽松计划将纳入价值120亿美元的企业债
  • 新浪美股 · 7分钟前
  • 美联储放松监管将赋予银行做市能力
  • 新浪美股 · 8分钟前
  • 愉悦资本回应瑞幸咖啡涉嫌造假:以SEC官方披露的信息为准
  • 新浪财经综合 · 18分钟前
  • 午盘:美股维持涨势 原油大幅拉升
  • 新浪美股 · 18分钟前

所属板块

生物技术和医学研究
+2.17%
制药与医学研究
+1.65%

热门股票

代码
价格
涨跌幅

BPMX 简况

BioPharmX Corporation is a specialty pharmaceutical company. The Company is focused on utilizing its drug delivery technologies to develop and commercialize prescription and over-the-counter (OTC) products that address markets in women's health and dermatology. Its portfolio of product candidates includes two clinical stage product candidates: BPX01, which is a topical antibiotic for the treatment of acne based on a formulation of minocycline, and BPX03, which is a molecular iodine (I2) tablet for the treatment of benign breast pain associated with fibrocystic breast condition (FBC) and cyclic mastalgia. Its VI2OLET is an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort and is clinically demonstrated to alleviate the symptoms associated with FBC, including tenderness, aches and swelling. It is developing BPX02, which is an injectable utilizing biologic materials for aesthetic dermatology applications.
展开

微牛提供Biopharmx Corp(AMEX-BPMX)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的BPMX股票新闻,以帮助您做出投资决策。